JP2023513592A5 - - Google Patents

Info

Publication number
JP2023513592A5
JP2023513592A5 JP2022549070A JP2022549070A JP2023513592A5 JP 2023513592 A5 JP2023513592 A5 JP 2023513592A5 JP 2022549070 A JP2022549070 A JP 2022549070A JP 2022549070 A JP2022549070 A JP 2022549070A JP 2023513592 A5 JP2023513592 A5 JP 2023513592A5
Authority
JP
Japan
Prior art keywords
amino acid
polypeptide
acid sequence
seq
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513592A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017856 external-priority patent/WO2021163481A1/en
Publication of JP2023513592A publication Critical patent/JP2023513592A/ja
Publication of JP2023513592A5 publication Critical patent/JP2023513592A5/ja
Pending legal-status Critical Current

Links

JP2022549070A 2020-02-14 2021-02-12 ポリペプチド及びそれらの使用(関連出願の相互参照) Pending JP2023513592A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062977036P 2020-02-14 2020-02-14
US62/977,036 2020-02-14
PCT/US2021/017856 WO2021163481A1 (en) 2020-02-14 2021-02-12 Polypeptides and their use

Publications (2)

Publication Number Publication Date
JP2023513592A JP2023513592A (ja) 2023-03-31
JP2023513592A5 true JP2023513592A5 (cg-RX-API-DMAC7.html) 2024-02-19

Family

ID=77292738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549070A Pending JP2023513592A (ja) 2020-02-14 2021-02-12 ポリペプチド及びそれらの使用(関連出願の相互参照)

Country Status (10)

Country Link
US (1) US20230075095A1 (cg-RX-API-DMAC7.html)
EP (1) EP4103586A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023513592A (cg-RX-API-DMAC7.html)
KR (1) KR20220142471A (cg-RX-API-DMAC7.html)
AU (1) AU2021220958A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016197A2 (cg-RX-API-DMAC7.html)
CL (2) CL2022002215A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022011395A2 (cg-RX-API-DMAC7.html)
PE (1) PE20230486A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021163481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114933657B (zh) * 2021-08-25 2024-02-02 上海交通大学医学院 神经生长因子突变体重组蛋白及其应用
KR102527221B1 (ko) * 2021-10-15 2023-05-02 에스케이바이오사이언스 주식회사 단백질의 정제방법
US20250215055A1 (en) * 2022-04-07 2025-07-03 University Of Washington Secretion-optimized de novo designed protein nanoparticles for eukaryotic expression and genetic delivery
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
AU2024265411A1 (en) 2023-05-01 2025-11-06 University Of Washington Pre-fusion-stabilized cmv gb protein nanostructures
AR133824A1 (es) * 2023-09-15 2025-11-05 Icosavax Inc Proteínas virales y nanoestructuras y usos de estas
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation
WO2025144636A1 (en) * 2023-12-26 2025-07-03 The Scripps Research Institute ENGINEERED hMPV F PROTEIN IMMUNOGENS AND RELATED VACCINES
WO2025207938A1 (en) * 2024-03-29 2025-10-02 University Of Washington Nucleic acid vaccines against coccidioidomycosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2568788A1 (en) * 2004-06-16 2005-12-29 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
US9630994B2 (en) * 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
WO2016138525A1 (en) * 2015-02-27 2016-09-01 University Of Washington Polypeptide assemblies and methods for the production thereof
WO2016199898A1 (ja) * 2015-06-10 2016-12-15 公立大学法人 富山県立大学 活性型変異酵素の製造方法および新規活性型変異酵素、並びに可溶性化変異タンパク質の製造方法
WO2018047856A1 (ja) * 2016-09-06 2018-03-15 学校法人慶應義塾 融合タンパク質、構造体、捕集剤、捕集する方法、dna、及びベクター
US11866699B2 (en) * 2017-02-10 2024-01-09 University Of Washington Genome editing reagents and their use
EP3606942B1 (en) * 2017-04-04 2025-06-11 University of Washington Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
CN112088014B (zh) * 2018-02-28 2026-03-24 华盛顿大学 自组装纳米结构疫苗
AU2019285048B2 (en) * 2018-06-13 2023-06-08 The Scripps Research Institute Nanoparticle vaccines with novel structural components
FR3083804B1 (fr) * 2018-07-13 2022-08-12 Institut Nat Des Sciences Appliquees De Toulouse Micro-organismes et procede pour la production d'acide glycolique a partir de pentoses et d'hexoses

Similar Documents

Publication Publication Date Title
JP2023513720A5 (cg-RX-API-DMAC7.html)
Bao et al. Phage-based vaccines
CN115246874B (zh) 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用
JP2010516290A5 (cg-RX-API-DMAC7.html)
JP2014506450A5 (cg-RX-API-DMAC7.html)
JP2021515572A5 (cg-RX-API-DMAC7.html)
JP2015521467A5 (cg-RX-API-DMAC7.html)
JP2019523648A5 (cg-RX-API-DMAC7.html)
JP2017221201A5 (cg-RX-API-DMAC7.html)
JP2021523695A5 (cg-RX-API-DMAC7.html)
TWI250164B (en) Highly purified cytokine activating factor and methods of use
JP2017519763A5 (cg-RX-API-DMAC7.html)
JP2010535504A5 (cg-RX-API-DMAC7.html)
CN113476600B (zh) Avc-29作为疫苗佐剂的用途以及含有该佐剂的疫苗组合物
AU2013339846B2 (en) Chimeric vaccine antigens against hepatitis C virus
JP4797149B2 (ja) インフルエンザウイルスに対するベクターワクチン
JP2018505697A5 (cg-RX-API-DMAC7.html)
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
WO2017205454A1 (en) Immunogens, compositions, and methods for treating dyslipidemia
CN101880328B (zh) 微小隐孢子虫Th多表位基因和融合蛋白及其应用
JP2008500802A5 (cg-RX-API-DMAC7.html)
CA3222356A1 (en) Compositions and methods to increase coronavirus immune response
JP2024534178A5 (cg-RX-API-DMAC7.html)
JP2025511108A5 (cg-RX-API-DMAC7.html)
Kisakov et al. Delivery of a DNA vaccine encoding SARS-CoV-2 receptor-binding domain (RBD) by electroporation